PCM
KDNY

Pentwater Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Pentwater Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-465,000
Closed -$17.9M – 108
2023
Q2 		$17.9M Buy
+465,000
New +$17.9M 0.12% 32